These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


167 related items for PubMed ID: 4391558

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Denervation augments alpha-2 but not alpha-1 adrenergic responses in canine saphenous veins.
    Flavahan NA, Miller VM, Aarhus LL, Vanhoutte PM.
    J Pharmacol Exp Ther; 1987 Feb; 240(2):589-93. PubMed ID: 3027319
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Nonadrenergic nature of prazosin-resistant, sympathetic contraction in the dog mesenteric artery.
    Muramatsu I, Kigoshi S, Oshita M.
    J Pharmacol Exp Ther; 1984 May; 229(2):532-8. PubMed ID: 6425493
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Accumulation and release of [3H]-5-hydroxytryptamine in saphenous veins and cerebral arteries of the dog.
    Verbeuren TJ, Jordaens FH, Herman AG.
    J Pharmacol Exp Ther; 1983 Aug; 226(2):579-88. PubMed ID: 6875866
    [Abstract] [Full Text] [Related]

  • 32. Influence of inhibitors of prostaglandin synthesis on venoconstrictor responses to bradykinin.
    Goldberg MR, Chapnick BM, Joiner PD, Hyman AL, Kadowitz PJ.
    J Pharmacol Exp Ther; 1976 Aug; 198(2):357-65. PubMed ID: 948031
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Blood pressure lowering effects of N,N-di-n-propyl-dopamine in rats: evidence for stimulation of peripheral dopamine receptors leading to inhibition of sympathetic vascular tone.
    Cavero I, Lefèvre-Borg F, Gomeni R.
    J Pharmacol Exp Ther; 1981 Aug; 218(2):515-24. PubMed ID: 7252851
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Coronary vasodilatation produced by dopamine after adrenergic blockade.
    Schuelke DM, Mark AL, Schmid PG, Eckstein JW.
    J Pharmacol Exp Ther; 1971 Feb; 176(2):320-7. PubMed ID: 4998690
    [No Abstract] [Full Text] [Related]

  • 37. Neuropeptide Y-induced potentiation of noradrenergic vasoconstriction in the human saphenous vein: involvement of endothelium generated thromboxane.
    Fabi F, Argiolas L, Ruvolo G, del Basso P.
    Br J Pharmacol; 1998 May; 124(1):101-10. PubMed ID: 9630349
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.